BRCA/HRD genetic status does not increase toxicity to PARP inhibitors or next-line cytotoxic chemotherapy in women with epithelial ovarian cancer (479)Alyssa Wield,Alicia Liu,Christine McGough,Jessica Berger,Michelle Boisen,Lan Coffman,Robert Edwards,Madeleine Courtney-Brooks,Jamie Lesnock,Alexander Olawaiye,Paniti Sukumvanich,Ronald Buckanovich,Haider Mahdi,Sarah TaylorGynecologic Oncology（2022）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
